Digital rendering of BeiGene's manufacturing site in Hopewell, NJ (Credit: BeiGene)

March 14, 2024 12:36 PM EDT

BeiGene looks beyond China as it secures new API source, nears opening of US site

Anna Brown

News Reporter

With many biopharma companies auditing their manufacturing supply chains, BeiGene will soon activate a second API supplier outside of China and will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

BeiGene looks beyond China as it secures new API source, nears opening of US site

Anna Brown

News Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Pfizer’s prostate cancer data leak, show promising results in early-stage study

Novartis returns for its anticoagulant in up to $3.1B buy of Blackstone’s Anthos

Judge halts some NIH cuts after 22 states sue

Merck KGaA confirms interest in acquiring cancer biotech SpringWorks

Trump’s tariff impact likely ‘minimal’ for brand-name drugmakers, manufacturing partners

Reducing risk in drug development: The importance of validated MRD testing in lymphoid cancers

BeiGene looks be­yond Chi­na as it se­cures new API source, nears open­ing of US site

News Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

BeiGene looks beyond China as it secures new API source, nears opening of US site